Latest News

Date Title Topic
30 Jun 2015 Translating Basic Research to the Patient’s Bedside Translational research
29 Jun 2015 First HDAC Inhibitor for Treatment of Multiple Myeloma Recommended for Approval in EU Haematologic malignancies - Anticancer agents & Biologic therapy
24 Jun 2015 Targeted Treatment for Hypoxic Conditions Translational research
23 Jun 2015 ESMO Press Release: ESMO President 2018-2019 Announced
23 Jun 2015 Four Distinct Genomic Subtypes of Cutaneous Melanoma Translational research - Melanoma
Breast Cancer
22 Jun 2015 European Commission Approves Nivolumab, for Both First-Line and Previously Treated Patients With Advanced Melanoma Melanoma - Cancer Immunology and Immunotherapy
10 Jun 2015 Therapeutic Dual Inhibition of HER2 Pathway in the HERACLES Trial Personalised medicine - Gastrointestinal cancers - Anticancer agents & Biologic therapy
09 Jun 2015 PALOMA3 Results Show that Palbociclib in Combination With Fulvestrant Could Offer an Effective and Less Toxic Treatment Option for Endocrine-Resistant Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
08 Jun 2015 Liver-Directed Therapy With SIRT, Using Y-90 Resin Microspheres, Plus FOLFOX-Based First-Line Chemotherapy for mCRC Gastrointestinal cancers
02 Jun 2015 Nivolumab vs Docetaxel in Advanced Non-Squamous Cell NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
Programme
28 May 2015 ESMO Press Release: Challenges Ahead for European Clinical Trials
28 May 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Generic Bortezomib Haematologic malignancies - Anticancer agents & Biologic therapy
27 May 2015 The New Global Era of Cancer Research Translational research